Skip to main content
CRBU logo

CRBU · Caribou Biosciences, Inc.

$1.65 +0.03 (+1.85%) At close · Jul 21
Market Cap
$164.14M
Shares
99.18M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Rachel Haurwitz $1,840,965
Sriram Ryali $1,029,413
Barbara McClung $919,574
Fiscal 2024
Executive Total
Rachel Haurwitz $4,213,245
Tim Kelly $1,913,370
Barbara McClung $1,612,819
Steven Kanner $1,612,819
Fiscal 2023
Executive Total
Rachel Haurwitz $3,116,547
Syed Rizvi $1,268,277
Steven Kanner $1,217,807
Barbara McClung $1,217,807
Fiscal 2022
Executive Total
Syed Rizvi $2,388,492
Ruhi Khan $1,038,077
Rachel Haurwitz $833,468
Fiscal 2021
Executive Total
Rachel Haurwitz $6,249,919
Jason O’Byrne $3,449,030
Barbara McClung $2,743,054
Fiscal 2020
Executive Total
Rachel Haurwitz $663,900
Barbara McClung $504,150
Jason O’Byrne
Key facts CIK 1619856 CUSIP 142038108 13F (30d) 12 filings 10 filers Visit website Investor relations